Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

18:25
06/24/18
06/24
18:25
06/24/18
18:25

Novo Nordisk to hold an investor and analyst event

In conjunction with the American Diabetes Association's 78th Scientific Sessions, Management holds an Investor and Analyst Event in Orlando, FL on June 24 at 7 pm. Webcast Link

  • 24

    Jun

NVO Novo Nordisk
$46.84

0.435 (0.94%)

06/01/18
ROTH
06/01/18
NO CHANGE
Target $400
ROTH
Buy
Roth Capital ups Madrigal price target to $400, examines possible M&A scenarios
Roth Capital analyst Yasmeen Rahimi noted that Madrigal Pharmaceuticals' (MDGL) "impressive" NASH resolution results published yesterday resulted in the stock's value being pushed up to make it the highest among "purely NASH" companies. Among large pharma companies, Rahimi believes those with the strongest metabolic franchises, large R&D teams, and sales forces focused on endocrinologists, gastroenterologists, and hepatologists likely have eyes on NASH assets, listing Merck (MRK), AstraZeneca (AZN), Eli Lilly (LLY) and Novo Nordisk (NVO) as examples. The historical acquisition price for NASH assets ranges from $200M to $1.7B, but Rahimi argues that Madrigal "can set the highest NASH price tag yet," estimating a potential takeout valuation of $5.6B. Rahimi raised her price target on Madrigal shares to $400 from $210 and keeps a Buy rating on the stock.
04/05/18
RHCO
04/05/18
NO CHANGE
Target $101
RHCO
Buy
Eli Lilly supported by positive oncology and diabetes findings, says SunTrust
SunTrust analyst John Boris keeps his Buy rating and $101 price target on Eli Lilly (LLY), citing the latest developments in Oncology and Diabetes. In Oncology, Boris points to the positive Overall Survival and Progression Free Survival data for Cyramza in second-line hepatocellular carcinoma, though he sees the commercial opportunity in Hepatocellular Carcinoma as limited. In Diabetes, the analyst points to the latest data showing Trulicity gaining market share on Novo Nordisk's (NVO) Victoza in the GLP-1 market.
02/26/18
JPMS
02/26/18
NO CHANGE
Target $105
JPMS
Overweight
Concerns over Eli Lilly diabetes franchise overdone, says JPMorgan
JPMorgan analyst Chris Schott believes longer-term growth concerns surrounding Trulicity and Eli Lilly's (LLY) broader diabetes franchise are overdone following Novo Nordisk's (NVO) oral semaglutide results as well as the launch of Ozempic. The analyst sees a buying opportunity in shares of Eli Lilly following the recent pullback. Lilly is a "highly diversified growth story" and competition to Trulicity is manageable, Schott tells investors in a research note. He keeps an Overweight rating on the shares with a $105 price target.
01/22/18
FBCO
01/22/18
DOWNGRADE
Target $82
FBCO
Underperform
Credit Suisse downgrades Lilly to Underperform on mid-term guidance concerns
Credit Suisse analyst Vamil Divan downgraded Eli Lilly (LLY) to Underperform from Neutral and cut his price target for the shares to $82 from $88. The analyst does not believe Lilly is on track to hit its mid-term guidance of 5% annual sales growth from 2015-2020. Divan notes he's $500M below consensus for Trulicity in 2021 based on market share gains for Novo Nordisk's (NVO) Victoza following its recent label expansion, the threat from Novo's once-weekly Ozempic and risk from upcoming Phase 3 data for Novo's oral semaglutide. Trulicity accounts for 40% of Lilly's sales growth from 2016-2021 based on current expectations, Divan tells investors in a research note partially titled "Diabetes Challenges Leave Sour Taste in Our Mouth"

TODAY'S FREE FLY STORIES

I

Intelsat

$36.25

3.81 (11.74%)

14:25
10/16/18
10/16
14:25
10/16/18
14:25
Options
Intelsat call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
10/16/18
10/16
14:25
10/16/18
14:25
Conference/Events
Financial Stability Oversight Council to hold a meeting »

The Council will provide…

WBA

Walgreens Boots Alliance

$75.55

0.83 (1.11%)

, AMZN

Amazon.com

$1,811.22

50.23 (2.85%)

14:23
10/16/18
10/16
14:23
10/16/18
14:23
Periodicals
Walgreens CEO says buyout of AmerisourceBergen possible, Bloomberg reports »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$75.55

0.83 (1.11%)

AMZN

Amazon.com

$1,811.22

50.23 (2.85%)

CVS

CVS Health

$73.05

0.01 (0.01%)

AET

Aetna

$199.90

0.88 (0.44%)

ABC

AmerisourceBergen

$92.51

2.93 (3.27%)

RAD

Rite Aid

$1.05

-0.005 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

  • 06

    Nov

RP

RealPage

$58.71

2.33 (4.13%)

14:22
10/16/18
10/16
14:22
10/16/18
14:22
Hot Stocks
RealPage pays $3M to settle FTC charges over tenant screening »

RealPage has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MARA

Marathon Patent Group

$0.62

-0.0034 (-0.55%)

14:18
10/16/18
10/16
14:18
10/16/18
14:18
Hot Stocks
Breaking Hot Stocks news story on Marathon Patent Group »

Merrick D. Okamoto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/16/18
10/16
14:17
10/16/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/16/18
10/16
14:16
10/16/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$220.75

5.47 (2.54%)

14:07
10/16/18
10/16
14:07
10/16/18
14:07
Recommendations
Goldman Sachs analyst commentary  »

JMP Securities sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 26

    Oct

DLTR

Dollar Tree

$86.09

5.11 (6.31%)

, DG

Dollar General

$110.50

4.08 (3.83%)

14:07
10/16/18
10/16
14:07
10/16/18
14:07
Recommendations
Dollar Tree, Dollar General, Amazon.com analyst commentary  »

Reported Icahn stake in…

DLTR

Dollar Tree

$86.09

5.11 (6.31%)

DG

Dollar General

$110.50

4.08 (3.83%)

AMZN

Amazon.com

$1,808.50

47.51 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

CAG

Conagra Brands

$36.10

0.2725 (0.76%)

, PF

Pinnacle Foods

$66.45

0.22 (0.33%)

14:04
10/16/18
10/16
14:04
10/16/18
14:04
Conference/Events
Pinnacle Foods to host special shareholder meeting »

Special Shareholder…

CAG

Conagra Brands

$36.10

0.2725 (0.76%)

PF

Pinnacle Foods

$66.45

0.22 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CRON

Cronos Group

$11.66

-0.07 (-0.60%)

14:00
10/16/18
10/16
14:00
10/16/18
14:00
Options
Cronos short-term calls active as shares see up and down action »

Cronos short-term calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABC

AmerisourceBergen

$90.56

0.98 (1.09%)

, WBA

Walgreens Boots Alliance

$75.52

0.8 (1.07%)

13:50
10/16/18
10/16
13:50
10/16/18
13:50
Periodicals
Walgreens CEO 'doesn't rule out' deal with AmerisourceBergen, Bloomberg says »

Walgreens (WBA) CEO…

ABC

AmerisourceBergen

$90.56

0.98 (1.09%)

WBA

Walgreens Boots Alliance

$75.52

0.8 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CJREF

Corus Entertainment

$0.00

(0.00%)

13:49
10/16/18
10/16
13:49
10/16/18
13:49
Upgrade
Corus Entertainment rating change  »

Corus Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVMT

Dell Technologies

$95.51

0.52 (0.55%)

13:46
10/16/18
10/16
13:46
10/16/18
13:46
Periodicals
Dell still thinks offer 'in best interest of DVMT shareholders,' Bloomberg says »

Dell Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
10/16/18
10/16
13:45
10/16/18
13:45
General news
U.S. corporate bond update: several financials are on tap »

U.S. corporate bond…

FDC

First Data

$23.61

0.56 (2.43%)

13:40
10/16/18
10/16
13:40
10/16/18
13:40
Options
8K First Data Jan 25 - 27 call spreads trade for 55c »

8K First Data Jan 25 - 27…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 29

    Oct

  • 03

    Mar

SNE

Sony

$57.24

0.99 (1.76%)

, BTC

Bitcoin

$0.00

(0.00%)

13:35
10/16/18
10/16
13:35
10/16/18
13:35
Hot Stocks
Sony developing rights management system for digital content using blockchain »

Sony Corporation, Sony…

SNE

Sony

$57.24

0.99 (1.76%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
10/16/18
10/16
13:35
10/16/18
13:35
General news
Treasury Option Action: 10-year positioning »

Treasury Option Action:…

TTWO

Take-Two

$131.41

3.43 (2.68%)

, ATVI

Activision Blizzard

$77.79

2.09 (2.76%)

13:31
10/16/18
10/16
13:31
10/16/18
13:31
Hot Stocks
Game On: Pachter says 'Red Dead Online' could be 25% as popular as 'GTA Online' »

Welcome to "Game…

TTWO

Take-Two

$131.41

3.43 (2.68%)

ATVI

Activision Blizzard

$77.79

2.09 (2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

WHR

Whirlpool

$108.01

2.6 (2.47%)

13:26
10/16/18
10/16
13:26
10/16/18
13:26
Periodicals
AHAM reports U.S. shipments of major home appliances down 0.4% in September »

The Association of Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SYMC

Symantec

$20.20

0.42 (2.12%)

13:25
10/16/18
10/16
13:25
10/16/18
13:25
Options
Symantec call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Dec

13:25
10/16/18
10/16
13:25
10/16/18
13:25
Conference/Events
Credit Suisse energy analysts to hold an analyst/industry conference call »

Energy Analysts, along…

SGRY

Surgery Partners

$14.56

0.34 (2.39%)

, UNH

UnitedHealth

$270.48

10.68 (4.11%)

13:21
10/16/18
10/16
13:21
10/16/18
13:21
Hot Stocks
Surgery Partners strength attributed to TheDeal.com discussion of M&A potential »

Shares of Surgery…

SGRY

Surgery Partners

$14.56

0.34 (2.39%)

UNH

UnitedHealth

$270.48

10.68 (4.11%)

HCA

HCA Healthcare

$134.76

1.9 (1.43%)

THC

Tenet

$26.32

0.69 (2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 30

    Oct

  • 06

    Nov

IBM

IBM

$144.39

3.27 (2.32%)

, AMZN

Amazon.com

$1,799.99

39 (2.21%)

13:19
10/16/18
10/16
13:19
10/16/18
13:19
Earnings
Fly Intel: What to watch for in IBM's earnings report »

IBM (IBM) is scheduled to…

IBM

IBM

$144.39

3.27 (2.32%)

AMZN

Amazon.com

$1,799.99

39 (2.21%)

MSFT

Microsoft

$110.61

3.01 (2.80%)

ORCL

Oracle

$48.18

1.06 (2.25%)

GOOG

Alphabet

$1,117.65

25.65 (2.35%)

GOOGL

Alphabet Class A

$1,130.17

28.59 (2.60%)

GRPN

Groupon

$3.59

0.085 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

XENT

Intersect ENT

$28.91

-1 (-3.34%)

, REGN

Regeneron

$396.44

18.64 (4.93%)

13:18
10/16/18
10/16
13:18
10/16/18
13:18
Recommendations
Intersect ENT, Regeneron analyst commentary  »

Regeneron data won't…

XENT

Intersect ENT

$28.91

-1 (-3.34%)

REGN

Regeneron

$396.44

18.64 (4.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 28

    Oct

  • 06

    Nov

  • 27

    Nov

  • 28

    Apr

  • 13

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.